Answer:
The lock-and-key model:
c. Enzyme active site has a rigid structure complementary
The induced-fit model:
a. Enzyme conformation changes when it binds the substrate so the active site fits the substrate.
Common to both The lock-and-key model and The induced-fit model:
b. Substrate binds to the enzyme at the active site, forming an enzyme-substrate complex.
d. Substrate binds to the enzyme through non-covalent interactions
Explanation:
Generally, the catalytic power of enzymes are due to transient covalent bonds formed between an enzyme's catalytic functional group and a substrate as well as non-covalent interactions between substrate and enzyme which lowers the activation energy of the reaction. This applies to both the lock-and-key model as well as induced-fit mode of enzyme catalysis.
The lock and key model of enzyme catalysis and specificity proposes that enzymes are structurally complementary to their substrates such that they fit like a lock and key. This complementary nature of the enzyme and its substrates ensures that only a substrate that is complementary to the enzyme's active site can bind to it for catalysis to proceed. this is known as the specificity of an enzyme to a particular substrate.
The induced-fit mode proposes that binding of substrate to the active site of an enzyme induces conformational changes in the enzyme which better positions various functional groups on the enzyme into the proper position to catalyse the reaction.
Answer: True no need for an explanation..
Answer:
334.08 g
Explanation:
87 proof = 43.5%
in 1L of liquid there is 43.5% alcohol/ethanol
1L (43.5/100) = 0.435 L alcohol
we want density in g/L because that's the volume u have
density 0.798 g/mL = 798 g/L
multiply the volume of alcohol by its density to get grams
0.435 L(798 g/L) = 334.08 g
psychologist might specialize in an area such as substance abuse treatment, child mental health, adult mental health, or geriatric mental health.
S<span>plit people in two groups of Casodex resistant treatment men (double -blind cross-over study) </span>
<span>50% get Casodex 50 mg ( BICALUTAMIDE 50 MG ) 1 tablet daily + 1 placebo tablet </span>
<span>Casodex is an anti testosterone agent. </span>
<span>50% get Casodex 50 mg 1 tablet daily + 1 Tamoxifen 20 mg tablet </span>
<span>Tamoxifen is an estrogen receptor inhibitor </span>
<span>Compare the results of tumor growth over 1 year's time then reverse the groups without the physician or the patient knowing if they are receiving tamoxifen or the placebo tamxoifen then compare tumor growth results again.</span>